Abstract:Phasing of heterozygous alleles is critical for interpretation of cis -effects of disease-relevant variation. For population studies, phase is often inferred from external data but read-based phasing approaches that span long genomic distances would be more accurate because they enable both genotype and phase to be obtained from a single dataset. To demonstrate how read-based phasing can provide functional insights, we sequenced 477 individuals with Cystic Fibrosis (CF) using linked-read sequencing. We benchmark read-based phasing with different short- and long-read sequencing technologies, prioritize linked-read technology as the most informative and produce a benchmark phase call set from reference sample HG002 for the community. The 477 samples display an average phase block N50 of 4.39 Mb. We use these samples to construct a graph representation of CFTR haplotypes, which facilitates understanding of complex CF alleles. Fine-mapping and phasing of the chr7q35 trypsinogen locus associated with CF meconium ileus demonstrates a 20 kb deletion and a PRSS2 missense variant p.Thr8Ile (rs62473563) independently contribute to meconium ileus risk (p=0.0028, p=0.011, respectively) and are PRSS2 pancreas eQTLs (p=9.5e-7 and p=1.4e-4, respectively), explaining the mechanism by which these polymorphisms contribute to CF. Phase enables access to haplotypes that can be used for genome graph or reference panel construction, identification of cis -effects, and for understanding disease associated loci. The phase information from linked-reads provides a causal explanation for variation at a CF-relevant locus which also has implications for the genetic basis of non-CF pancreatitis to which this locus has been reported to contribute. ### Competing Interest Statement DMC received an honorarium for teaching module development for Vertex Pharmaceuticals. NM is doing contract research trials for Vertex Phaemaceuticals and Abbvie. ALS has received speaking fees for educational programs sponsored by Vertex Pharmaceuticals. BSQ has received speaker fees from Vertex Pharmaceuticals and has served as site PI for several Vertex-sponsored clinical trials. WML is a study investigator for Vertex Pharmaceuticals. ET and FR act as consultants for Vertex Pharmaceuticals. MS participated in Vertex clinical trials and received payment for education modules. SM, AC, JG, FL, BT, WWLS, JW, ZW, RVP, KK, AH, NP, JA, CW, GCM, SB, DA, EB, CB, MC, AP, MP, RVW, DH, MJS, ET, PW, LS, FR, and LJS have no conflicts of interest. * CF : cystic fibrosis CFTR : cystic fibrosis transmembrane conductance WGS : whole genome sequencing GWAS : genome-wide association studies MI : meconium ileus LD : linkage disequilibrium PacBio : Pacific Biosciences 10XG : 10x Genomics CGMS : Canadian CF Gene Modifier Study Consortium CLR : PacBio continuous long-reads CCS : PacBio circular consensus sequence VCF : variant call format GIAB : Genome in a Bottle HMW : high molecular weight TCAG : The Centre for Applied Genomics GTEx : Genotype-Tissue Expression ER : endoplasmic reticulum SRP : signal recognition particle QC : quality control

Phased nanopore assembly with Shasta and modular graph phasing with GFAse

Pseudo-Sanger Sequencing: Massively Parallel Production of Long and Near Error-Free Reads Using NGS Technology

Gapless assembly of complete human and plant chromosomes using only nanopore sequencing

Comparison of the Two Up-to-date Sequencing Technologies for Genome Assembly: HiFi Reads of Pacific Biosciences Sequel II System and Ultralong Reads of Oxford Nanopore

Pre-Assembly NGS Correction of ONT Reads Achieves HiFi-Level Assembly Quality

Phasing Nanopore Genome Assembly by Integrating Heterozygous Variations and Hi-C Data

Nanopore sequencing and assembly of a human genome with ultra-long reads

Simultaneous de novo calling and phasing of genetic variants at chromosome-scale using NanoStrand-seq

Phasing or purging: tackling the genome assembly of a highly heterozygous animal species in the era of high-accuracy long reads

Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation

Matching excellence: Oxford Nanopore Technologies' rise to parity with Pacific Biosciences in genome reconstruction of non-model bacterium with high G+C content

Nanopore sequencing and the Shasta toolkit enable efficient de novo assembly of eleven human genomes

Matching Excellence: ONT’s Rise to Parity with PacBio in Genome Reconstruction of Non-Model Bacterium with High GC Content

Fully phased human genome assembly without parental data using single-cell strand sequencing and long reads

Oxford Nanopore sequencing, hybrid error correction, and de novo assembly of a eukaryotic genome

High Quality Phasing Using Linked-Read Whole Genome Sequencing of Patient Cohorts Informs Genetic Understanding of Complex Traits

Efficient whole genome haplotyping and high-throughput single molecule phasing with barcode-linked reads

Haplotype-aware variant calling with PEPPER-Margin-DeepVariant enables high accuracy in nanopore long-reads

Phasing Diploid Genome Assembly Graphs with Single-Cell Strand Sequencing

HiPhase: jointly phasing small, structural, and tandem repeat variants from HiFi sequencing

“Evaluating the Benefits and Limits of Multiple Displacement Amplification with Whole-Genome Oxford Nanopore Sequencing”